Gene · 55869
Papers3,134
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
461 to 480 of 3,134
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Differential chondrogenic differentiation between iPSC derived from healthy and OA cartilage is associated with changes in epigenetic regulation and metabolic transcriptomic signatures. | Elife | 2023 | 36715686 | PubTator, text mining | PubMed |
| A replication fork determinant for the establishment of sister chromatid cohesion. | Cell | 2023 | 36693376 | PubTator, text mining | PubMed |
| Genotype and phenotype characteristics of West syndrome in 20 Vietnamese children: Two novel variants detected by next-generation sequencing. | Epilepsy Res | 2023 | 36689859 | PubTator, text mining | PubMed |
| Design, Synthesis, anticancer evaluation and in silico studies of 2,4,6-trimethoxychalcone derivatives. | Saudi Pharm J | 2023 | 36685294 | PubTator, text mining | PubMed |
| Potential Therapies Targeting the Metabolic Reprogramming of Diabetes-Associated Breast Cancer. | J Pers Med | 2023 | 36675817 | PubTator, text mining | PubMed |
| A Novel Variant in RAD21 in Cornelia De Lange Syndrome Type 4: Case Report and Bioinformatic Analysis. | Genes (Basel) | 2023 | 36672860 | PubTator, text mining | PubMed |
| Drugs Targeting p53 Mutations with FDA Approval and in Clinical Trials. | Cancers (Basel) | 2023 | 36672377 | PubTator, text mining | PubMed |
| Propionate exerts neuroprotective and neuroregenerative effects in the peripheral nervous system. | Proc Natl Acad Sci U S A | 2023 | 36669102 | PubTator, text mining | PubMed |
| Epigenomic signatures reveal mechanistic clues and predictive markers for autism spectrum disorder. | Mol Psychiatry | 2023 | 36650278 | PubTator, text mining | PubMed |
| NCBP2 and TFRC are novel prognostic biomarkers in oral squamous cell carcinoma. | Cancer Gene Ther | 2023 | 36635327 | PubTator, text mining | PubMed |
| Whole-Exome Sequencing Identified a Novel DYRK1A Variant in a Patient With Intellectual Developmental Disorder, Autosomal Dominant 7. | Cureus | 2023 | 36628390 | PubTator, text mining | PubMed |
| Intimate communications within the tumor microenvironment: stromal factors function as an orchestra. | J Biomed Sci | 2023 | 36600243 | PubTator, text mining | PubMed |
| Novel dual LSD1/HDAC6 inhibitor for the treatment of cancer. | PLoS One | 2023 | 36595522 | PubTator, text mining | PubMed |
| HDAC7 inhibits cell proliferation via NudCD1/GGH axis in triple-negative breast cancer. | Oncol Lett | 2023 | 36589669 | PubTator, text mining | PubMed |
| [Analysis of genotypes and phenotypes of three children with Cornelia de Lange syndrome]. | Zhonghua Yi Xue Yi Chuan Xue Za Zhi | 2023 | 36584992 | PubTator, text mining | PubMed |
| Novel pyridine-containing histone deacetylase inhibitors strongly arrest proliferation, induce apoptosis and modulate miRNAs in cancer cells. | Eur J Med Chem | 2023 | 36549114 | PubTator, text mining | PubMed |
| A Versatile Strategy for Screening Custom-Designed Warhead-Armed Cyclic Peptide Inhibitors. | Angew Chem Int Ed Engl | 2023 | 36535892 | PubTator, text mining | PubMed |
| Difluoromethyl-1,3,4-oxadiazoles are slow-binding substrate analog inhibitors of histone deacetylase 6 with unprecedented isotype selectivity. | J Biol Chem | 2023 | 36528061 | PubTator, text mining | PubMed |
| Structure-Based Discovery of Selective Histone Deacetylase 8 Degraders with Potent Anticancer Activity. | J Med Chem | 2023 | 36516047 | PubTator, text mining | PubMed |
| Nonmuscle myosin IIA promotes the internalization of influenza A virus and regulates viral polymerase activity through interacting with nucleoprotein in human pulmonary cells. | Virol Sin | 2023 | 36509386 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/55869/papers?page=24